182 related articles for article (PubMed ID: 11728266)
1. Cytochrome p450-mediated cardiovascular drug interactions.
Cheng JW
Heart Dis; 2000; 2(3):254-8. PubMed ID: 11728266
[TBL] [Abstract][Full Text] [Related]
2. Updates on cytochrome P450-mediated cardiovascular drug interactions.
Cheng JW; Frishman WH; Aronow WS
Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
[TBL] [Abstract][Full Text] [Related]
3. Updates on cytochrome p450-mediated cardiovascular drug interactions.
Cheng JW; Frishman WH; Aronow WS
Dis Mon; 2010 Mar; 56(3):163-79. PubMed ID: 20189501
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-mediated cardiovascular drug interactions.
Scheen AJ
Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1065-82. PubMed ID: 21810031
[TBL] [Abstract][Full Text] [Related]
5. Avoiding psychotropic drug interactions in the cardiovascular patient.
DeVane CL; Markowitz JS
Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic drug metabolism in the cancer patient: clinical aspects of management of potential drug interactions.
Kalash GR
Psychooncology; 1998; 7(4):307-20. PubMed ID: 9741070
[TBL] [Abstract][Full Text] [Related]
7. Common CYP450 drug interactions with psychiatric medicines: A brief review for the primary care physician.
Kutscher EC; Carnahan R
S D Med; 2006 Jan; 59(1):5-9. PubMed ID: 16610463
[TBL] [Abstract][Full Text] [Related]
8. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
Wijnen PA; Op den Buijsch RA; Drent M; Kuijpers PM; Neef C; Bast A; Bekers O; Koek GH
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450: new nomenclature and clinical implications.
Cupp MJ; Tracy TS
Am Fam Physician; 1998 Jan; 57(1):107-16. PubMed ID: 9447218
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.
Mach CM; Fugii H; Wakame K; Smith J
J Soc Integr Oncol; 2008; 6(3):105-9. PubMed ID: 19087767
[TBL] [Abstract][Full Text] [Related]
11. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
Sikka R; Magauran B; Ulrich A; Shannon M
Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
[TBL] [Abstract][Full Text] [Related]
12. Drug metabolism and drug interactions in the elderly.
Herrlinger C; Klotz U
Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):897-918. PubMed ID: 11866484
[TBL] [Abstract][Full Text] [Related]
13. Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants.
Bachmann KA; Lewis JD
Ann Pharmacother; 2005 Jun; 39(6):1064-72. PubMed ID: 15886285
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450-mediated drug interactions.
Flockhart DA; Oesterheld JR
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):43-76. PubMed ID: 10674190
[TBL] [Abstract][Full Text] [Related]
15. [Do Cardizem and Waran interact?].
Lakartidningen; 2008 Feb 6-12; 105(6):373. PubMed ID: 18380356
[No Abstract] [Full Text] [Related]
16. Inhibitory effects on cytochrome p450 enzymes of pentamidine and its amidoxime pro-drug.
Bürenheide A; Kunze T; Clement B
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):61-5. PubMed ID: 18346045
[TBL] [Abstract][Full Text] [Related]
17. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.
Elbarbry FA; Marfleet T; Shoker AS
Transplantation; 2008 May; 85(9):1222-9. PubMed ID: 18475175
[TBL] [Abstract][Full Text] [Related]
19. [The role of genetic polymorphisms of cytochrome P450 in drug metabolism used in the treatment of cardiovascular diseases].
Wojtczak A; Skretkowicz J
Kardiol Pol; 2009 Sep; 67(9):1011-4. PubMed ID: 19838960
[No Abstract] [Full Text] [Related]
20. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.
Bjornsson TD; Callaghan JT; Einolf HJ; Fischer V; Gan L; Grimm S; Kao J; King SP; Miwa G; Ni L; Kumar G; McLeod J; Obach RS; Roberts S; Roe A; Shah A; Snikeris F; Sullivan JT; Tweedie D; Vega JM; Walsh J; Wrighton SA; ;
Drug Metab Dispos; 2003 Jul; 31(7):815-32. PubMed ID: 12814957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
